Piper Sandler reiterates Overweight on Bristol-Myers Squibb
Piper Sandler reiterated an Overweight rating on Bristol-Myers Squibb with a $82.00 price target, implying 28.7% upside from the Sep 15 close of $63.73.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.